Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Masimo CorporationNASDAQ: MASI

Other Income / Expenses · Q1 FY2026 · quarter ended Apr 2026

Other income / expenses remains negative

Q1 FY2026 other income / expenses was -$6.1M, compared with -$9.6M a year earlier. Trailing-twelve-month other income / expenses was -$33.8M.

Context

  • Other income / expenses amounted to 2.6% of revenue in FY2025, up 0.8 pp from a year earlier.
  • Other income / expenses grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -$6.1M or moves back toward the trailing-twelve-month quarterly average of -$8.45M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
-$6.1M+38.4% QoQ
Last fiscal yearJan 2026
-$40.2M-4.1% YoY
LTMApr 2026
-$33.8M+19.1% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.5%——
1 year-4.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
(40.2M) USD
Year-over-year change
-4.1%

Other Income / Expenses vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +19.1% is the 2nd highest of 11, against a peer median of -17.4%.
  • Other income / expenses amounts to 2.2% of revenue for MASI, versus a peer median of 1.7%.
MASI Competitors
Other Income / Expenses for MASI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$115.4M USD-49.1%—4.5%
STVNStevanato Group S.p.A.LTM Jun 2026-€4.88M EUR-15.7%—0.4%
RYTMRhythm Pharmaceuticals, Inc.LTM Sep 2026-$5M USD+12.0%—1.8%
RGENRepligen CorporationLTM Jun 2026-$13.15M USD-228.1%—1.7%
ATRAptarGroup, Inc.LTM Jun 2026-$32.08M USD-19.1%—0.8%
MASIMasimo CorporationLTM Apr 2026-$33.8M USD+19.1%—2.2%
ABVXAbivax S.A.FY2025-€84.2M EUR-2484.3%——
AVTRAvantor, Inc.LTM Jun 2026-$186.4M USD+12.4%—2.8%
BAXBaxter International Inc.LTM Jun 2026-$209M USD+28.2%—1.8%
MOHMolina Healthcare, Inc.LTM Sep 2026-$213M USD-22.4%—0.5%
HSICHenry Schein, Inc.LTM Jun 2026-$216M USD+11.1%—1.6%
Peer median (excluding MASI) —-17.4%—1.7%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue1.24B2.04B2.05B2.09B1.53B
Cost of Revenue430.8M977M1.04B1.09B581.7M
Gross Profit808.4M1.06B1B1B945.2M
Gross Margin65.2%52.0%49.0%48.0%61.9%
Research & Development137.2M191.4M175.2M222.8M126.4M
Selling, General & Admin395.4M657.4M664M743.8M506M
Operating Expenses532.6M848.8M867M1.27B632.4M
Depreciation & Amortization35.6M136.1M98.3M103M38.8M
EBITDA310.3M355.2M236.7M(158.7M)344.6M
EBITDA Margin25.0%17.4%11.6%-7.6%22.6%
Operating Income275.8M210M136.5M(266.7M)312.8M
Operating Margin22.3%10.3%6.7%-12.7%20.5%
Interest Income900K1.8M3M4.8M3.4M
Interest Expense300K25.7M50.3M43.6M33.2M
Other Income / Expenses(1.4M)(16.6M)(48.4M)(38.6M)(40.2M)
Income Before Tax274.4M193.4M88.1M(305.3M)272.6M
Pre-Tax Margin22.1%9.5%4.3%-14.6%17.9%
Income Tax Expense44.8M49.9M6.6M(400K)64.9M
Net Income229.6M143.5M81.5M(304.9M)(151.5M)
Net Margin18.5%7.0%4.0%-14.6%-9.9%
EPS (Basic)4.162.681.54(5.72)(2.83)
EPS (Diluted)3.982.601.51(5.72)(2.80)
Weighted Avg Shares55.17M53.6M52.8M53.3M53.6M
Weighted Avg Shares (Diluted)57.68M55.2M54.1M53.3M54.2M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.